Skip to main content
Submitted by Dr S. Patel on 8 October 2021

Patients with advanced cancer often experience cachexia. This is extremely distressing to caregivers. Dr. Arjun Gupta, gastrointestinal oncologist and researcher addresses questions on this difficult topic.

What is cachexia?

People with cancer often experience weight loss, loss of muscle mass, and become weaker as the cancer progresses. Their quality of life decreases, and they may experience increased toxicity from cancer treatments. This collection of symptoms is called ‘’cachexia’’. It is often accompanied by reduced appetite (‘’anorexia’’).

Cachexia can affect patients with any advanced and/or serious illness (heart failure, lung disease, AIDS etc.) and is not limited to cancer.

How is it diagnosed? what are the signs and symptoms caregivers should look out for?

Oncologists are often able to diagnose cachexia during clinic visits, based on symptoms and physical examination. Common symptoms of cachexia include weight loss, loss of muscle mass, fat loss, loss of appetite, loss of muscle strength, fatigue, and difficulty performing daily activities. These can be distressing to patients and often even more so to caregivers.

How is it different from weight loss and anorexia?

Cachexia is unique in that it is not simply due to reduced intake of calories. Rather it is related to the underlying cancer which has multiple effects on appetite, metabolism, and muscle breakdown. Even if a patient with cachexia was to receive extra calories, it would not reverse the underlying process driving cachexia.

What is the treatment for cachexia in early stages?

Cachexia is thought to progress through 3 stages: pre-cachexia, cachexia, and refractory cachexia. When clinicians typically refer to cachexia, they mean more of the later stages of cachexia. By that time, the process is essentially irreversible and patients already have established weight loss and muscle loss.

Early identification (at the pre-cachexia stage) may be more amenable to interventions. These may include dietary counseling, psychosocial support, and medications to improve appetite if needed. Exercise may also have a role in promoting and maintaining muscle strength and function.

Treating the underlying cause (cancer) is the best way to treat cachexia when possible.

How is it treated in late stage?

In late stages of cachexia, especially when there are no effective anti-cancer treatments, providing extra calories through artificial feeding (tube feeding into the stomach or through intravenous lines) is unlikely to cause benefit, and can instead result in harm and burden. Medications also have very limited role in improving late-stage cachexia.

Providing counseling and psychological support to patients and caregivers is perhaps the most important treatment at end-of-life. Good quality palliative care and treating other symptoms that patients have (e.g., nausea, mouth sores etc.) can improve quality of life.

What is the prognosis for people who have this?

People with advanced cancer and cachexia that is progressive usually do not have good anti-cancer treatments available. Their prognosis is often in the order of weeks to a few months.

What are the psychosocial factors associated with cachexia?

Across cultures, eating and the foods we eat are emotional issues. This extends to the acts of planning, preparing, and offering foods to those we love. Cooking and feeding others are often expressions of hope, care, and love. These are strong connections that are common among people. When someone is at the end of life, offering food is a natural way for people to want to offer love and comfort for the person with cancer. For cancer caregivers, feeding someone offers the hope of control over a situation in which they otherwise have little control.

Caregivers may see appetite loss as their failure to provide good care. This may lead to feelings of helplessness, guilt, and rejection when the person they are caring for is unable to eat. Caregivers may believe that if they are unable to feed the person they are caring for, it will result in the person dying earlier. However, this is not true, and caregivers should not blame themselves if their loved one is unable to eat.

What would be your advice to care providers?

In people with advanced cancer, especially at the end of life, appetite loss and cachexia represents the effects of the cancer. It is not the caregiver’s fault if the person they are caring for does not have an appetite or experiences weight loss.

Caregivers can support the person with cancer in loving, nonjudgmental ways.

  • If the person has a desire to eat, listen for favorite foods that they might mention and offer those.
  • Do not pressure or force them to eat. This can make appetite loss worse and add tension to your relationship.
  • Focus on the social aspects of the meal, such as eating for pleasure, eating for taste, or enjoying company at the dinner table.
  • Do not focus on how much food is eaten or how many calories are consumed.

For loved ones who do not want to eat, caregivers can consider alternative methods to show their love and care:

  • Holding hands
  • Providing lip balm
  • Giving a massage
  • Providing companionship

Any tips on how patients can prevent cachexia?

There is no magical wand that can prevent cachexia. It is often a function of the underlying cancer. Patients can be vigilant about reporting their symptoms (appetite, weight, psychological distress) to their healthcare team and doing their best (while being comfortable) to eat, exercise, and have meaningful relationships with caregivers.

Bio:

Dr. Arjun Gupta is an Assistant Professor at the University of Minnesota, Minneapolis, USA. He is a gastrointestinal oncologist, a symptom management enthusiast, and a health services researcher. His research specifically examines cancer care access and delivery, the costs of cancer care, and the hidden burdens imposed on and faced by people with cancer and their caregivers while receiving this care.

Community
Condition

Stories

  • Esophageal Cancer Made Swallowing Of Even Ice Cream Hard
    When Mr. Sudhir Waghmare, 58, PhD, entrepreneur and innovator, was diagnosed with esophageal cancer he took it in his stride quite stolidly. What broke him down was the loss during chemotherapy of his luscious hair which he dearly cherished. He shares his personal narrative. My background I am an entrepreneur and innovator of a company engaged in manufacturing new born life saving devices since the last 31 years. I have a PhD degree in Neonatal Intensive care equipment. I am married to…
  • मैं कैंसर से नहीं मरूंगी
    मुंबई की 56 वर्षीय रश्मि सचदे को 15 साल पहले गैस्ट्रोइंटेस्टाइनल स्ट्रोमल ट्यूमर (जीआईएसटी) का निदान मिला था। वे कैंसर को एक पेइंग गेस्ट की तरह मानती हैं और अपनी कैंसर यात्रा को अपनी आस्था और हँसते रहने की प्रवृत्ति के सहारे संभालती हैं। 2004 की बात है।, मैंने देखा कि मेरा पेट फूलने लगा था और जब मैं सोने के लिए लेटती तो विशेष रूप से एक तरफ बहुत सख्त लगता। मुझे उस समय फूले हुए पेट के अलावा कोई अन्य स्वास्थ्य संबंधी शिकायत नहीं थी – पर पेट इतना फूला रहता कि लोग पूछने लगे कि क्या मैं गर्भवती हूं।…
  • Profile picture of Uday Kerwar Bladder cancer survivor and Ostomy India Chairperson framed in a blue background with the bladder cancer tricolour ribbon
    You Adapt To The Bladder Bag Like You Do To Eye-Glasses
    Uday Kerwar, survivor of stage 4 bladder cancer and currently Chairman of Ostomy Association of India (OAI) talks about his journey with bladder cancer, urostomy bags, its many challenges and plenty of adjustments before it becomes a part of you. Please tell us a little about yourself.  I am 62 and retired. Since 2016 I am continuously associated with Ostomy Association of India (OAI), a Charitable Trust providing rehabilitative support to people who have undergone Ostomy (life-saving…
  • Head shot of a bespectacled woman wearing a black and red dress and red necklace
    मेरे ब्रेन ट्यूमर के निदान ने मुझे बोल्ड बना दिया
    जब बेंगलुरु की 38 वर्षीया ए चित्रा को सीज़र होने लगे, तो शुरू में उनका एपिलेप्सी (मिर्गी) के लिए इलाज किया गया, लेकिन अंततः उन्हें मैलिग्नेंट ग्लियोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान मिला। वे बताती हैं कि कैसे उन्होंने डॉक्टरों, परिवार, दोस्तों और अपनी कंपनी की टीम के समर्थन से अपनी बीमारी के उपचार और भावनात्मक पीड़ा को संभाला। कृपया हमें अपनी स्थिति के बारे में कुछ बताएं मुझे एनाप्लास्टिक एस्ट्रोसाइटोमा ग्रेड 3 नामक ब्रेन ट्यूमर का निदान मिला था। यह एक दुर्लभ, मैलिग्नेंट ट्यूमर है जिसे…
  • ब्रेन ट्यूमर होने के बाद मेरी पहली प्राथमिकता मेरा स्वास्थ्य है
    30 वर्षीय मेल्विन जॉर्ज इस लेख में एस्ट्रोसाइटोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान प्राप्त करने, देखभाल के विकल्पों का आकलन करने और निर्णय लेने, और कैंसर के उपचार और सम्बंधित दुष्प्रभाव पर चर्चा करते हैं और साझा करते हैं  कि इन सब अनुभव और चुनौतियों ने उन्हें व्यक्तिगत रूप से कैसे प्रभावित किया और रिकवरी में उनकी आस्था उनका मुख्य सहारा कैसे बनी रही।  चौंकाने वाला निदान 11 जुलाई 2017 का दिन। मैं अपने छात्रावास के कमरे में अपने बिस्तर पर लेटा हुआ था और जैसे ही मैं जाका, मैंने देखा…
  • The author, a woman in a red and yellow sari and a yellow blouse, holding birds
    मैंने अपनी आवाज पैसिव स्मोकिंग (निष्क्रिय धूम्रपान) के कारण खो दी
    धूम्रपान न करने वाली 72 वर्षीया नलिनी सत्यनारायण को 10 साल पहले उनके घर में सेकेंड हैंड धुएं के संपर्क में आने के कारण गले (वॉयस बॉक्स) के कैंसर का निदान मिला। आज, उत्तरजीवी के रूप में, वे एक ऊर्जावान तंबाकू नियंत्रण योद्धा बन गई हैं और ऐसे लोगों को परामर्श देती हैं जिन्होंने स्वरयंत्र (लैरिन्क्स) की सर्जरी करवाई है जिसमें उनका वॉयस बॉक्स हटाया गया है - वे उन्हें कृत्रिम वॉयस बॉक्स से बात करना सिखाती हैं। आपने कब और कैसे अपने गले की समस्या को पहचाना? जनवरी 2010 की बात है। मुझे लगा कि मेरा गला…
  • Should Time Toxicity Be A Factor In Informed Decision Making?
    Patients with advanced cancers often contemplate the time burden of their cancer care. What does this exactly entail? Dr Arjun Gupta, an Oncologist and Researcher, recently wrote a paper about Time Toxicity for Cancer patients. He helps us understand this new concept and how it can affect quality of life for patients. What is ‘’time toxicity’’? We have seen tremendous progress in oncology in the past few decades. Yet, for advanced solid cancers, average survival benefits offered by new…
  • Webinar: Ovarian Cancer Awareness and Management
    This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer. Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk. Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate. We bring together a…
  • A panel discussion on Kidney Cancer with the profile pictures of the panelists
    Demystifying Kidney Cancer : Key Webinar takeaways
    Renal cell carcinoma is the most common type of adult kidney cancer, making up about 85% of diagnoses. And yet it is rarely talked about.  Kidney Cancer is also an area which has seen significant progress in treatment options. Key takeaways from the webinar are given below.  An expert panel talked about kidney cancer and answered questions and concerns that patients have. The panelists are Dr. KL Jayakumar, MD Radiation Oncology. Professor and HOD, Sreemookambika Cancer center,…
  • Webinar: Towards Patient Centred Access To Quality Cancer Care - Challenges
    PatientsEngage and EHA Consortium invite you to an interactive webinar series on Patient Centred Access to Quality Cancer Care. In the first of the series aligned to the UICC theme of "Close the Care Gap", we are very privileged to have an esteemed and diverse panel who will highlight the challenges faced in equitable access to quality cancer care and identify the areas where we still need to make progress. The panelists are Dr. CS Pramesh, Director Tata Memorial Hospital; Convener National…